跳至主要内容
临床试验/NCT02725008
NCT02725008已完成3 期

A Randomized Double Blinded Placebo Controlled Trial of One Versus Two Doses of Oral Dexamethasone for the Treatment of Acute Asthma Exacerbation in the Pediatric Emergency Department (ED)

Geoffrey W Jara-Almonte1 个研究点 分布在 1 个国家目标入组 99 人开始时间: 2015年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
99
试验地点
1
主要终点
Treatment Failure

研究概览

简要总结

Comparing one versus two doses of oral dexamethasone for the treatment of asthma in the pediatric emergency department.

详细描述

A randomized double blinded placebo controlled trial comparing one dose of dexamethasone administered in the Emergency Department with two doses, the first given in the emergency department and the second 24 hours after the index ED visit.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Months 至 20 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • History of asthma defined as at least two (2) prior episodes of respiratory illness characterized by wheezing treated with inhaled beta agonists

排除标准

  • pregnancy
  • severe chronic cardiac, respiratory, neurological or neuromuscular disease
  • complete resolution of symptoms after one treatment of beta agonists
  • severe asthma symptoms as defined by a Pulmonary Index Score of 12 or greater

研究组 & 干预措施

Control

Active Comparator

Patients are given one dose of oral dexamethasone 0.6 milligrams per kilogram up to 16 milligrams in the ED and a second dose of 0.6 milligrams per kilogram up to 16 milligrams to take 24 hours after ED visit

干预措施: Dexamethasone (Drug)

Investigational

Experimental

Patients are given one dose of oral dexamethasone 0.6 milligrams per kilogram up to 16 milligrams in the ED and placebo to be taken 24 hours after ED visit

干预措施: Dexamethasone (Drug)

Investigational

Experimental

Patients are given one dose of oral dexamethasone 0.6 milligrams per kilogram up to 16 milligrams in the ED and placebo to be taken 24 hours after ED visit

干预措施: placebo (Drug)

结局指标

主要结局

Treatment Failure

时间窗: 5 days

number of patients who experience any of the following outcomes - unplanned hospital admission for asthma symptoms, unplanned ED visit for asthma symptoms, unplanned urgent care visit for asthma symptoms, unplanned primary care physician visit for asthma symptoms, or prescription of a course of steroids

次要结局

  • Change in Symptom Severity From Day 1 to Day 5(5 days)

研究者

发起方
Geoffrey W Jara-Almonte
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Geoffrey W Jara-Almonte

Sub-Investigator

New York Presbyterian Brooklyn Methodist Hospital

研究点 (1)

Loading locations...

相似试验